In 2009, John W. Cumming earned $1.41M in total compensation at Hologic, including $925.00K salary and $194.25K bonus. Most recently sold 18,182 shares in Jul 2021. Currently holds stock worth $1.28M. Led Hologic as CEO for 1 years.
Compensation History
Annual executive compensation data for John W. Cumming, including salary, bonuses, and stock awards.
Year
2009
Total Compensation
$1.41M
Salary
$925.00K
Bonus
$194.25K
Other
$291.38K
Salary
$925.00KBoard Justification
The compensation philosophy aims to attract and retain superior executive talent, aligning executive interests with those of stockholders, and providing competitive pay based on performance.
Bonus
$194.25KBoard Justification
Represents discretionary bonuses earned pursuant to our short term incentive plans.
Other Compensation
$291.38KBoard Justification
Includes contributions made by the company under the Supplemental Executive Retirement Plan, matching contributions made to the 401(k) Savings and Investment Plan, and other benefits.
Restricted Stock
Board Justification
No stock was vested in 2009 as the focus is on cash compensation and not stock grants.
Performance Metrics
Performance metrics included revenue targets and adjusted earnings per share (EPS) for determining bonuses.
John W. Cumming
Ex-CEO of Hologic
Education
Bachelor's degree in Business Administration
Field of Expertise
Business & Management
Sector of Economy
Healthcare
Born
March 19, 1953 - 72 years ago
CEO of Hologic for
1 year 5 months (May 2008 - Nov 2009)
Previous Experience
Former CEO of Hologic, Inc.
Other Hologic CEOs
Holdings
Track John W. Cumming's stock holdings and portfolio value over time.
Total Stock Sold
$2.82M
$2.82M
132,549 HOLX shares
What if they kept their stock?
If John W. Cumming didn't sell their stock, today they would have:
Extra HOLX132,549 shares worth $9.94M.
This is 252.03% and $7.11M more than what they got when they sold the stock.
Insider Trading
John W. Cumming's recent stock transactions, purchases, and sales filed with the SEC.
$1.76M
HOLX at $21.32/share
Mar 7, 2011
Sale
$1.06M
HOLX at $21.25/share
Mar 3, 2011
Sale
Rivals
Compare John W. Cumming with competitor CEOs and industry peers.
Adam Elsesser
CEO of Penumbra
2023 Compensation
Stock
$0.00
Salary
$600.00K
Bonus
$0.00
Other
$1.62K
Total Holdings
$215.94M
Stanley M. Bergman
CEO of Henry Schein
2023 Compensation
Stock
$0.00
Salary
$1.63M
Bonus
$643.65K
Other
$341.74K
Total Holdings
$49.43M
Fred P. Lampropoulos
Founder and CEO of Merit Medical Systems
2023 Compensation
Stock
$2.77M
Salary
$1.89M
Bonus
$1.34M
Other
$8.70K
Total Holdings
$38.99M
Bryan C. Hanson
CEO of Zimmer Biomet Holdings
2023 Compensation
Stock
$0.00
Salary
$1.26M
Bonus
$0.00
Other
$2.91M
Total Holdings
$199.99K